XML 61 R48.htm IDEA: XBRL DOCUMENT v3.10.0.1
Agreements - Roche (Details)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jan. 31, 2019
USD ($)
May 31, 2000
Dec. 31, 2018
USD ($)
Sep. 30, 2018
USD ($)
Jun. 30, 2018
USD ($)
Mar. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Sep. 30, 2017
USD ($)
Jun. 30, 2017
USD ($)
Mar. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Sep. 30, 2016
USD ($)
Jun. 30, 2016
USD ($)
Mar. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Sep. 30, 2015
USD ($)
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Jun. 30, 2016
USD ($)
Dec. 31, 2000
USD ($)
item
Collaborative Agreements disclosures                                              
Revenue from contract with customer     $ 13,416 $ 10,928 $ 9,287 $ 19,815 $ 39,448 $ 8,480 $ 39,020 $ 28,499 $ 13,846 $ 7,660 $ 7,408 $ 19,714 $ 18,029 $ 14,851 $ 21,506 $ 32,880 $ 53,446 $ 115,447 $ 48,628 $ 60,002  
Non-cash royalty revenue related to sale of future royalties                                 12,894   32,154 28,142   25,299  
License and milestone fees                                              
Collaborative Agreements disclosures                                              
Revenue from contract with customer     1,747 $ 672 $ 1,321 $ 11,540 $ 29,580 $ 79 $ 31,080 $ 18,730 $ 5,076 $ 76 $ 76 $ 10,077 10,692 $ 6,070 5,152 16,762 15,280 79,469 $ 15,305 26,915  
Royalty revenue                                              
Collaborative Agreements disclosures                                              
Revenue from contract with customer                             $ 195     $ 195       195  
Roche                                              
Collaborative Agreements disclosures                                              
Period in arrears to receive royalty reports and payments related to sales of Kadcyla   3 months                                          
Roche | Upfront payment                                              
Collaborative Agreements disclosures                                              
Revenue from contract with customer                                             $ 2,000
Roche | License and milestone fees                                              
Collaborative Agreements disclosures                                              
Potential milestone payment                                             44,000
Roche | Royalty revenue                                              
Collaborative Agreements disclosures                                              
Revenue from contract with customer                                 $ 12,900   32,200 $ 28,100   $ 25,300  
Roche | Kadcyla | Development milestones                                              
Collaborative Agreements disclosures                                              
Revenue from contract with customer                                     13,500        
Potential milestone payment                                             13,500
Roche | Kadcyla | Regulatory milestones                                              
Collaborative Agreements disclosures                                              
Revenue from contract with customer                                     20,500        
Potential milestone payment     5,000                               5,000       30,500
Roche | Undisclosed Target                                              
Collaborative Agreements disclosures                                              
Revenue from contract with customer                                             1,000
Potential milestone payment                                             $ 38,000
Number of undisclosed targets with exclusive licenses | item                                             4
Roche | Undisclosed Target | Development milestones                                              
Collaborative Agreements disclosures                                              
Potential milestone payment                                             $ 8,000
Roche | Undisclosed Target | Regulatory milestones                                              
Collaborative Agreements disclosures                                              
Potential milestone payment                                             20,000
Roche | Undisclosed Target | Milestone payments                                              
Collaborative Agreements disclosures                                              
Potential milestone payment                                             $ 10,000
Roche | Undisclosed Target | IND application filed                                              
Collaborative Agreements disclosures                                              
Potential milestone payment     $ 1,000                               $ 1,000        
OMERS | Kadcyla | Subsequent event                                              
Collaborative Agreements disclosures                                              
Non-cash royalty revenue related to sale of future royalties $ 65,200